Kore Private Wealth LLC Denali Therapeutics Inc. Transaction History

Kore Private Wealth LLC

  • $554 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$23.13 - $38.84 $11,565 - $19,420
-500 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$14.4 - $19.99 $7,200 - $9,995
500 New
500 $9,000
Q2 2019

Aug 14, 2019
SELL
$18.5 - $28.14 $18,500 - $28,140
-1,000 Closed
0 $0
Q1 2019

May 16, 2019
BUY
$17.99 - $24.65 $17,990 - $24,650
1,000 New
1,000 $23,000

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Kore Private Wealth LLC Portfolio

Follow Kore Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kore Private Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email